Available to SourceHuman Prescription DrugDiabetes & Endocrine

Vabrinty (Leuprolide Acetate)

22.5 mg/.375mL · Injection Suspension Extended Release

By URONOVA PHARMACEUTICALS, INC.

Leuprolide Acetate · Injection, Suspension, Extended Release · 22.5 mg/.375mL · Subcutaneous

NDC: 85043-025
Route: Subcutaneous
Therapeutic class: Gonadotropin Releasing Hormone Receptor Agonist , Gonadotropin Releasing Hormone Receptor Agonists [MoA]
Marketing category: NDA AUTHORIZED GENERIC

Package sizes

1 SYRINGE in 1 CARTON (85043-025-02) / .375 mL in 1 SYRINGENDC 85043-025-02Available to Order

Request This Medication

*Expect a reply within 2 business hours with availability and pricing.

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request a quote

Request this medication.

Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.

DSCSA-compliant pedigree on every order
Cold-chain capable where applicable
Same-day fulfillment available for urgent needs

Related in Diabetes & Endocrine

See all →

Vabrinty (Leuprolide Acetate)

Package sizes

Additional information

Request this medication.

Related in Diabetes & Endocrine

Omeosport

Guna-Geriatrics

Procort (1.85% Hydrocortisone Acetate - 1.15% Pramoxine Hci Cream)

1% Hydrocortisone